Incident atrial fibrillation in patients with differentiated thyroid cancer : a meta-analysis
Differentiated thyroid cancer (DTC) represents the most common form of thyroid neoplasms and is becoming increasingly prevalent. Evidence suggests a possible relationship between DTC diagnosis and subsequent atrial fibrillation (AF). If confirmed, this may present an alarming health risk (AF) in an otherwise condition with a relatively good prognosis (DTC). The aim of this systematic review and meta-analysis is to provide for the first time a pooled estimate of AF incidence in DTC patients in comparison to healthy controls. A detailed search in electronic databases, clinical trial registries and grey literature was performed to identify studies reporting the incidence of AF in DTC patients. Newcastle-Ottawa quality assessment scale was used to assess study quality. We used a random effects (RE) generalized linear mixed model (GLMM) in pooling of individual studies and also calculated a prediction interval for the estimate of a new study. Six observational studies met the eligibility criteria, which included totally 187,754 patients with DTC and 199,770 healthy controls. The median follow-up period was 4.3 to 18.8 years; the incidence rate of AF was 4.86 (95% CI, 3.29 to 7.17, I2 = 96%) cases per 1000 person-years, while the incidence rate ratio was 1.54 (95% CI, 1.44 to 1.65, I2 = 0%, 95% PI, 1.33 to 1.78).This is the first meta-analysis to confirm that patients with DTC are at a high risk for developing AF, which may be attributed to a state of iatrogenic hyperthyroidism due to long-term thyrotropin suppression therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Endocrine-related cancer - 28(2021), 5 vom: 29. Apr., Seite 325-335 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kostopoulos, Georgios [VerfasserIn] |
---|
Links: |
---|
Themen: |
9002-71-5 |
---|
Anmerkungen: |
Date Completed 14.04.2022 Date Revised 14.04.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1530/ERC-20-0496 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM323500129 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM323500129 | ||
003 | DE-627 | ||
005 | 20231225184321.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1530/ERC-20-0496 |2 doi | |
028 | 5 | 2 | |a pubmed24n1078.xml |
035 | |a (DE-627)NLM323500129 | ||
035 | |a (NLM)33794503 | ||
035 | |a (PII)ERC-20-0496 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kostopoulos, Georgios |e verfasserin |4 aut | |
245 | 1 | 0 | |a Incident atrial fibrillation in patients with differentiated thyroid cancer |b a meta-analysis |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.04.2022 | ||
500 | |a Date Revised 14.04.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Differentiated thyroid cancer (DTC) represents the most common form of thyroid neoplasms and is becoming increasingly prevalent. Evidence suggests a possible relationship between DTC diagnosis and subsequent atrial fibrillation (AF). If confirmed, this may present an alarming health risk (AF) in an otherwise condition with a relatively good prognosis (DTC). The aim of this systematic review and meta-analysis is to provide for the first time a pooled estimate of AF incidence in DTC patients in comparison to healthy controls. A detailed search in electronic databases, clinical trial registries and grey literature was performed to identify studies reporting the incidence of AF in DTC patients. Newcastle-Ottawa quality assessment scale was used to assess study quality. We used a random effects (RE) generalized linear mixed model (GLMM) in pooling of individual studies and also calculated a prediction interval for the estimate of a new study. Six observational studies met the eligibility criteria, which included totally 187,754 patients with DTC and 199,770 healthy controls. The median follow-up period was 4.3 to 18.8 years; the incidence rate of AF was 4.86 (95% CI, 3.29 to 7.17, I2 = 96%) cases per 1000 person-years, while the incidence rate ratio was 1.54 (95% CI, 1.44 to 1.65, I2 = 0%, 95% PI, 1.33 to 1.78).This is the first meta-analysis to confirm that patients with DTC are at a high risk for developing AF, which may be attributed to a state of iatrogenic hyperthyroidism due to long-term thyrotropin suppression therapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a atrial fibrillation | |
650 | 4 | |a differentiated thyroid cancer | |
650 | 4 | |a meta-analysis | |
650 | 4 | |a systematic review | |
650 | 7 | |a Thyrotropin |2 NLM | |
650 | 7 | |a 9002-71-5 |2 NLM | |
700 | 1 | |a Doundoulakis, Ioannis |e verfasserin |4 aut | |
700 | 1 | |a Antza, Christina |e verfasserin |4 aut | |
700 | 1 | |a Bouras, Emmanouil |e verfasserin |4 aut | |
700 | 1 | |a Nirantharakumar, Krishnarajah |e verfasserin |4 aut | |
700 | 1 | |a Tsiachris, Dimitrios |e verfasserin |4 aut | |
700 | 1 | |a Thomas, G Neil |e verfasserin |4 aut | |
700 | 1 | |a Lip, Gregory Y H |e verfasserin |4 aut | |
700 | 1 | |a Toulis, Konstantinos A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Endocrine-related cancer |d 1997 |g 28(2021), 5 vom: 29. Apr., Seite 325-335 |w (DE-627)NLM093797834 |x 1479-6821 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2021 |g number:5 |g day:29 |g month:04 |g pages:325-335 |
856 | 4 | 0 | |u http://dx.doi.org/10.1530/ERC-20-0496 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2021 |e 5 |b 29 |c 04 |h 325-335 |